FONR stock rises on cash merger as shareholders receive 19 dollars per share

FONR stock, representing shares of Fonar Corporation (ISIN US3444371021), has been converted into cash at a price of 19.00 USD per share in a completed merger that was reported as effective by September 2, 2026, according to data compiled by a major US brokerage platform. This cash merger, confirmed on September 2, 2026, fixes the payout level for former shareholders at 19.00 USD per share and effectively removes the stock from active trading on its primary listing venue.

Cash merger defines exit price

According to a corporate actions tracker maintained by a US brokerage, Fonar Corporation completed a cash merger in which each FONR share is redeemed for 19.00 USD in cash as of early September 2026. The tracker explicitly states that shares were removed and that shareholders will receive 19.00 USD per share in cash as consideration.

For investors, this cash price acts as a de facto final valuation for the company in the public market, because FONR stock will no longer trade freely after the corporate action settlement. The 19.00 USD level can be compared with earlier market prices from prior trading sessions, but as of September 2, 2026 the relevant figure for former shareholders is the cash amount per share they receive.

Merger payout and performance context

With the cash merger terms setting a payout of 19.00 USD per share as of September 2, 2026, the FONR stock exit price can be viewed relative to broader equity market trends in late summer 2026. On September 2, 2026 major US equity benchmarks such as the Dow Jones Industrial Average remained under pressure, with that index closing at 52,766.88 points after a decline of 0.8 percent on the session, according to a market summary published on the same date. This contrast highlights that FONR shareholders receive a fixed cash value at a time when overall stock market volatility is elevated.

Although the latest detailed quarterly financial figures for Fonar Corporation are not contained in the most recent day-filtered search results, the cash merger consideration of 19.00 USD per share nevertheless reflects the outcome of prior negotiations and assessments of the company’s value by the acquirer and Fonar’s board. Historically, Fonar had focused on niche medical imaging technologies, and the cash exit of 19.00 USD per share provides a clear benchmark against which long-term investors can measure their realized returns relative to their original purchase prices.

Medical imaging systems as core business

Before the cash merger, Fonar Corporation was known for its development and sale of medical imaging systems, particularly magnetic resonance imaging scanners designed for diagnostic use. These systems targeted hospitals, imaging centers and specialist clinics, forming the company’s primary revenue base in prior reporting periods.

While detailed segment data from the most recent fiscal year are outside the scope of the latest day-filtered sources, earlier public filings and investor materials have shown that medical imaging products and related services historically accounted for the bulk of Fonar’s revenue. This business focus makes the cash merger exit price of 19.00 USD per share a reference point for evaluating how capital markets ultimately valued the company’s imaging technology franchise.

FONR stock delisting and investor takeaway

Because the merger is structured as a cash transaction with a consideration of 19.00 USD per FONR share, the stock is expected to be delisted from its primary exchange after the corporate action is fully processed. As of September 2, 2026, the central market figure relevant to former shareholders is therefore the cash payout per share rather than an ongoing trading price, and no updated 52-week trading range is needed to assess the immediate financial outcome.

For investors, the key takeaway is that FONR stock has transitioned from a publicly traded share to a completed cash position at 19.00 USD per share as of early September 2026. This closes the chapter on Fonar Corporation’s presence in public equity markets and allows shareholders to redeploy the returned capital into other opportunities based on their individual risk and return preferences.

Fonar Corporation at a glance

• Company: Fonar Corporation
• ISIN: US3444371021
• Ticker: FONR
• Trading venue: NASDAQ
• Price (as of September 2, 2026): 19.00 USD (cash merger consideration per share)
• Sector / Industry: Health care / Medical equipment
• Index membership: None (small cap, not part of major headline indices)